Hemostemix Inc's stock surged by 7.69% in the last trading session, reflecting growing investor interest and confidence in the company.
In a notable turn of events, Hemostemix Inc (HEM.V) experienced a significant increase in its stock price, closing at CA$0.07 after gaining 7.69% in just one day. This uptick comes amidst ongoing financing activities that have captured the attention of investors.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeAdvertisement
Market cap
$13.32M
52W high
$0.14
52W low
$0.04
1W change
+15.38%
Beta
0.61
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1180.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1180.0% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
140.1%
Annualized
90-Day Vol
116.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.08 | C$0.05 – C$0.13 |
| 60 trading days | C$0.08 | C$0.04 – C$0.17 |
| 90 trading days | C$0.09 | C$0.04 – C$0.21 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the implications of Hemostemix's recent financing activities and their potential to advance the company's clinical and regulatory initiatives.
Hemostemix Inc Stock Up 7.69% in One Day
Market capitalization reached CA$13.32 million, reflecting the company's growing valuation as investor interest increases.
Bull case
The recent private placements show that Hemostemix is successfully raising capital. This could strengthen its operations and support the development of its ACP-01 therapy, which might lead to revenue growth in the future.
Bear case
Even with this positive movement, Hemostemix's stock remains speculative. The limited media coverage might indicate potential risks that investors should be aware of.
Market Performance Overview
Advertisement
Hemostemix Inc's stock price climbed to CA$0.07, marking a 7.69% increase in the last trading session. This rise is significant for a company with a market cap of CA$13.32 million, indicating a growing interest from investors. The recent surge reflects the potential optimism surrounding the company's ongoing financing efforts.
Recent Financing Activities
The company has been active in securing funds through private placements, raising over CA$1 million in recent months. These funds are aimed at advancing Hemostemix's regulatory and clinical initiatives related to its ACP-01 therapy, which is expected to play a crucial role in the company's future growth. Investors are closely watching how these initiatives will unfold.
Looking Ahead
As Hemostemix continues to navigate its financing and development strategies, investors should remain vigilant. The stock's recent performance may indicate a positive trend, but the speculative nature of small-cap stocks like HEM.V means that potential investors should conduct thorough research and consider the associated risks.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
